1 were eligible if they had current urinary incontinence,
and were excluded if they had a third degree or higher uterine pr
2 Caregivers were excluded if they had a diagnosed and untreated mental il
3 Females were excluded if they had a previous cancer diagnosis (except
4 Individuals were excluded if they had any previous prostate biopsy, exten
5 Individuals were excluded if they had dementia or metastatic cancer, were
6 Individuals were excluded if they had not been in the health-care system
7 Infants were excluded if they had existing risk factors for neurologi
8 Lesions were excluded if they had solid enhancing components.
9 Newborns were excluded if they had any evidence of another congenital
10 Participants were excluded if they had a history of or had received treatm
11 Participants were excluded if they had allergy to rice; history of cholera
12 Participants were excluded if they had been born prematurely (<37 weeks ge
13 Participants were excluded if they had multiple myeloma or any other B cel
14 Participants were excluded if they had neurological comorbidities that wer
15 Potential
participants were excluded if they had previous experience with any of the
16 Patients were excluded if they had a family history of parental consan
17 Patients were excluded if they had a previous revascularization.
18 Patients were excluded if they had a structural cerebral cause for the
19 Patients were excluded if they had active brain metastases or active a
20 Patients were excluded if they had acute viral croup, tracheal surgery
21 Patients were excluded if they had an open abdomen treatment in their
22 Patients were excluded if they had any of these events before the base
23 Patients were excluded if they had cognitive disabilities preventing t
24 Patients were excluded if they had comorbidities that associate with C
25 Patients were excluded if they had evidence of HCV genotype or subtype
26 Patients were excluded if they had HDV superinfection, liver infection
27 Patients were excluded if they had hypotension, defined as either the
28 Patients were excluded if they had implantable cardioverter defibrilla
29 Patients were excluded if they had less than 3 months of follow-up on
30 Patients were excluded if they had less than 3 months of follow-up.
31 Patients were excluded if they had not completed breast mound reconstr
32 Patients were excluded if they had one or more of the following diagno
33 Patients were excluded if they had previously had radiotherapy or did
34 Patients were excluded if they had previously undergone B-KPro implant
35 Patients were excluded if they had received a previous kidney transpla
36 Patients were excluded if they had received previous treatment with ti
37 Patients were excluded if they had stage 2 hypertension or known renal
38 Patients were excluded if they had systolic pulmonary artery pressure
39 Patients were excluded if they had unreliable VFs (fixation losses >33
40 Patients were excluded if they had upper urinary tract disease, urothe
41 Persons were excluded if they had a history of gout or had received g
42 Soldiers were excluded if they had a medical or psychiatric condition
43 Subjects were excluded if they had a history of a myocardial infarctio
44 Subjects were excluded if they had a previous diagnosis of chronic liv
45 Subjects were excluded if they had cardiac, pulmonary, liver, or kidne
46 Subjects were excluded if they had moderate or high levels of anticard
47 Potential
subjects were excluded if they had had previous glaucoma surgery or la
48 ia post-stroke at least 4 months before randomisation;
they were excluded if they had another premorbid speech and langua
49 Volunteers were excluded if they had eczema, psoriasis, or other chronic
50 Women were excluded if they had any signs of active cancer or were